IRD vs ZBRA · rev $2.9M vs P/E 28, rev $3.05B
Opus Genetics, Inc. (IRD) versus Zebra Technologies Corporation (ZBRA) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Zebra Technologies Corporation (ZBRA) is a communication equipment company listed on NASDAQ.
Latest reported IRD revenue for 2026-06-30 was $2.9M. Net income was -$73.6M. Revenue was up 35.0% from 2026-03-31 to 2026-06-30. IRD currently screens at market cap $35.7M.
Latest reported ZBRA revenue for 2026-07-04 was $3.05B. Net income was $368.0M. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
IRD currently screens at market cap $35.7M. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
Not investment advice. Open the IRD and ZBRA stock pages for the full models.
Not investment advice.